EFFICACY OF TRIPLE DMARD THERAPY IN RA PATIENTS WITH SUBOPTIMAL RESPONSES TO MTX - RESULTS OF AN OPEN-LABEL STUDY

被引：0
|
作者：
ODELL, J
HAIRE, C
EIRKSON, N
DRYMALSKI, W
PALMER, W
ECKHOFF, J
GARWOOD, V
MALOLEY, P
KLASSEN, L
WEES, S
KLEIN, H
MOORE, G
机构：
[1] VET ADM MED CTR,OMAHA,NE 68198
[2] UNIV NEBRASKA,MED CTR,RHEUMATOID ARTHRIT INVEST NETWORK,OMAHA,NE 68198
来源：
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF BIOLOGIC THERAPY VERSUS TRIPLE DMARD THERAPY IN RA PATIENTS UNRESPONSIVE TO METHOTREXATE
    Vernice, Nicholas A.
    Reiss, Allison B.
    Renna, Heather A.
    DeLeon, Joshua
    Carsons, Steven
    Kasselman, Lora J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (03) : 697 - 697
  • [22] Glucocorticoid Dose Is Progressively Reduced in Patients with RA Receiving Sarilumab: Results from the Open-Label EXTEND Study
    Fleischmann, Roy
    Selmi, Carlo
    Gonzalez-Gay, Miguel Angel
    van Hoogstraten, Hubert
    Hagino, Owen
    Rajput, Tejasweeni
    St John, Gregory
    Buttgereit, Frank
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Safety and efficacy of leflunomide plus etanercept combination therapy in patients with rheumatoid arthritis:: Results from an open-label pilot study
    Grünke, M
    Kalden, JR
    Manger, B
    Antoni, CE
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 421 - 421
  • [24] An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs
    Pope, Janet
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Bessette, Louis
    Lazovskis, Juris
    Haraoui, Boulos
    Sampalis, John S.
    RHEUMATOLOGY, 2020, 59 (07) : 1522 - 1528
  • [25] Efficacy and safety of efalizumab for nail psoriasis: Results of an open-label, multicenter study
    Rich, Phoebe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB130 - AB130
  • [26] Correlation of efficacy and quality of life in patients with epilepsy transitioned to oxcarbazepine monotherapy: Results of an open-label study
    Gates, JR
    Barkley, G
    Tatum, W
    D'Souza, J
    Constantine, S
    NEUROLOGY, 2002, 58 (07) : A295 - A296
  • [27] Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: Results of an open-label multicenter study in Japan
    Ishigooka, J
    Murasaki, M
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 353 - 363
  • [28] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 234 - 235
  • [29] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
  • [30] Argatroban Therapy in Pediatric Patients Requiring Nonheparin Anticoagulation: An Open-Label, Safety, Efficacy, and Pharmacokinetic Study
    Young, G.
    Boshkov, L. K.
    Sullivan, J. E.
    Raffini, L. J.
    Cox, D. S.
    Boyle, D. A.
    Kallender, H.
    Tarka, E. A.
    Soffer, J.
    Hursting, M. J.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (07) : 1103 - 1109
12345